India to Philippines: Erythromycin Export Trade Route
India has recorded 46 verified shipments of Erythromycin exported to Philippines, representing a combined trade value of $11.4M USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $247.1K USD. The leading Indian exporter is BDH INDUSTRIES LIMITED, which accounts for 49% of total export value with 4 shipments worth $5.6M USD. On the buying side, NELPA LIFESCIENCES INC is the largest importer in Philippines with $10.6M USD in purchases. The top 3 suppliers — BDH INDUSTRIES LIMITED, VINS INTERNATIONAL PRIVATE LIMITED, CENTURION LABORATORIES PRIVATE LIMITED — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Erythromycin corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $11.4M USD. The route is dominated by BDH INDUSTRIES LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's erythromycin manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $247.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 23.8%, placing it at rank #14 among India's top erythromycin export destinations globally.
On the import side, key buyers of Indian erythromycin in Philippines include NELPA LIFESCIENCES INC, PHILGEN PHARMACEUTICALS INC, GREEN CORE PHARMA INC.NO.460,RM and 10 others. NELPA LIFESCIENCES INC is the single largest importer with 9 shipments valued at $10.6M USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portCHAWAPAYAL ICD
Market Position
- Global rank#14
- Annual growth+23.8%
- Demand growth+21.9%
- Regulatory ease70/100
Top 10 Indian Erythromycin Exporters to Philippines
Showing top 10 of 15 Indian suppliers exporting Erythromycin to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BDH INDUSTRIES LIMITED Avg $1.4M per shipment | 4 | $5.6M | 49.0% |
| 2 | VINS INTERNATIONAL PRIVATE LIMITED Avg $5.0M per shipment | 1 | $5.0M | 43.7% |
| 3 | CENTURION LABORATORIES PRIVATE LIMITED Avg $33.2K per shipment | 5 | $165.8K | 1.5% |
| 4 | THEON PHARMACEUTICALS LIMITED Avg $13.4K per shipment | 12 | $160.7K | 1.4% |
| 5 | FLAMINGO PHARMACEUTICALS LIMITED Avg $42.7K per shipment | 2 | $85.4K | 0.8% |
| 6 | THEON PHARMACEUTICALS LTD Avg $15.6K per shipment | 5 | $78.0K | 0.7% |
| 7 | BDH HEALTHCARE PRIVATE LIMITED Avg $14.9K per shipment | 4 | $59.6K | 0.5% |
| 8 | DEEPA INTERNATIONAL Avg $19.5K per shipment | 3 | $58.5K | 0.5% |
| 9 | FLAMINGO PHARMACEUTICALS LTD Avg $25.8K per shipment | 2 | $51.5K | 0.5% |
| 10 | MICRO LABS LIMITED Avg $22.3K per shipment | 2 | $44.6K | 0.4% |
This table shows the top 10 of 15 Indian companies exporting erythromycin to Philippines, ranked by total trade value. The listed exporters are: BDH INDUSTRIES LIMITED, VINS INTERNATIONAL PRIVATE LIMITED, CENTURION LABORATORIES PRIVATE LIMITED, THEON PHARMACEUTICALS LIMITED, FLAMINGO PHARMACEUTICALS LIMITED , THEON PHARMACEUTICALS LTD, BDH HEALTHCARE PRIVATE LIMITED, DEEPA INTERNATIONAL, FLAMINGO PHARMACEUTICALS LTD, MICRO LABS LIMITED . BDH INDUSTRIES LIMITED is the dominant supplier with 4 shipments worth $5.6M USD, giving it a 49% market share. The top 3 suppliers together account for 94% of the total trade value on this route.
Showing top 10 of 15 total Indian exporters on the India to Philippines Erythromycin export route.
Top 10 Erythromycin Importers in Philippines
Showing top 10 of 13 known buyers in Philippines receiving Erythromycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian erythromycin in Philippines include NELPA LIFESCIENCES INC, PHILGEN PHARMACEUTICALS INC, GREEN CORE PHARMA INC.NO.460,RM, GREEN CORE PHARMA INC, H.H.C. , among 13 total buyers. The largest importer is NELPA LIFESCIENCES INC, accounting for $10.6M USD across 9 shipments — representing 93% of all erythromycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NELPA LIFESCIENCES INC | 9 | $10.6M | 93.2% |
| 2 | PHILGEN PHARMACEUTICALS INC | 4 | $165.3K | 1.5% |
| 3 | GREEN CORE PHARMA INC.NO.460,RM | 11 | $145.4K | 1.3% |
| 4 | GREEN CORE PHARMA INC | 6 | $93.4K | 0.8% |
| 5 | H.H.C. | 2 | $85.4K | 0.8% |
| 6 | NELPA LIFESCIENCES INC, NO.5 KM. 18 | 4 | $76.7K | 0.7% |
| 7 | HHC 12TH FLOOR | 2 | $51.5K | 0.5% |
| 8 | RITEMED PHILS,INC | 2 | $44.6K | 0.4% |
| 9 | PHILGEN PHARMACEUTICALS,INC. | 2 | $41.8K | 0.4% |
| 10 | H.H.C. | 1 | $38.2K | 0.3% |
Showing top 10 of 13 Erythromycin importers in Philippines on this route.
Top 10 Erythromycin Formulations Imported by Philippines
Showing top 10 of 35 product formulations shipped on the India to Philippines Erythromycin route, ranked by trade value
Philippines imports a wide range of erythromycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, ASCORSAPH-ERYSAPH T 500 (ERYTHROMYCINSTEARATE TABLETS USP 500 MG)(PACK OF 10 — accounts for $5.4M USD across 1 shipments. There are 35 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, ASCORSAPH-ERYSAPH T 500 (ERYTHROMYCINSTEARATE TABLETS USP 500 MG)(PACK OF 10 | 1 | $5.4M | 47.5% |
| 2 | PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, ERYTHCIN (ERYTHROMYCIN STEARATE TABLETS USP 500 MG) (PACK 10 X 10 T) | 1 | $5.0M | 43.7% |
| 3 | ERYTHROMYCIN AS STEARATE 500 MG TABLET TROMXENE | 3 | $123.9K | 1.1% |
| 4 | ERYTHROMYCIN 500MG TABLET (PERTUSTAT 500 | 3 | $123.6K | 1.1% |
| 5 | PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, ERYSAPH T500 (ERYTHROMYCIN STEARATE TABLETS USP 500 MG) | 1 | $59.4K | 0.5% |
| 6 | PHARMACEUTICAL PRODUCTS-HARMLESS MEDICINE-ERYSAPH T 500 (ERYTHROMYCIN STEARATE TABLETS USP 500 MG) | 3 | $58.5K | 0.5% |
| 7 | ERYSAPH T500 (Erythromycin Stearate Tabl | 1 | $58.4K | 0.5% |
| 8 | PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, ERYSAPH T 500 ((ERYTHROMYCIN STEARATETABLETS USP 500 MG)(PACK OF 10 X 10 T)NOS | 3 | $56.0K | 0.5% |
| 9 | ERYSAPH T500 Erythromycin Stearate Tablets USP 500mg Batch No NER 31 9900x10x10 T | 1 | $54.4K | 0.5% |
| 10 | ERYTHROMYCIN 500MG TABLET PERTUSTAT 500 10X10-BLISTER GREEN CARD NO.21168 VALID UPTO 31.03.2027 | 1 | $51.5K | 0.5% |
Showing top 10 of 35 Erythromycin formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
CHAWAPAYAL ICD handles the highest volume with 9 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's erythromycin exports to Philippines are driven primarily by a handful of large-scale manufacturers. BDH INDUSTRIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BDH INDUSTRIES LIMITED, VINS INTERNATIONAL PRIVATE LIMITED, CENTURION LABORATORIES PRIVATE LIMITED — together account for 94% of total trade value on this route. The average shipment value of $247.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products harmless medicine, erythcin (erythromycin stearate tablets usp 500 mg) (pack 10 x 10 t) and erythromycin as stearate 500 mg tablet tromxene, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NELPA LIFESCIENCES INC is the largest importer with 9 shipments worth $10.6M USD — representing 93% of all erythromycin imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $11.4M
- Avg. Shipment
- $247.1K
- Suppliers
- 15
- Buyers
- 13
- Transit (Sea)
- ~20 days
- Annual Growth
- +23.8%
Related Analysis
Other Erythromycin Routes
Unlock the Full India to Philippines Erythromycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 46 shipments on this route.
Frequently Asked Questions — India to Philippines Erythromycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Erythromycin to Philippines?
The leading Indian exporters of Erythromycin to Philippines are BDH INDUSTRIES LIMITED, VINS INTERNATIONAL PRIVATE LIMITED, CENTURION LABORATORIES PRIVATE LIMITED. BDH INDUSTRIES LIMITED holds the largest market share at approximately 49% of total trade value on this route.
Q What is the total value of Erythromycin exports from India to Philippines?
India exports Erythromycin to Philippines worth approximately $11.4M USD across 46 recorded shipments. The average value per shipment is $247.1K USD.
Q Which ports does India use to ship Erythromycin to Philippines?
The most active port of origin is CHAWAPAYAL ICD with 9 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Philippines for Erythromycin?
The average transit time for Erythromycin shipments from India to Philippines is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Philippines Erythromycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.8% with demand growth tracking at 21.9%. The route is ranked #14 among India's top Erythromycin export destinations globally.
Q How many suppliers are active on the India to Philippines Erythromycin route?
There are currently 15 active Indian suppliers exporting Erythromycin to Philippines. The market is moderately concentrated with BDH INDUSTRIES LIMITED accounting for 49% of total shipment value.
Q Who are the main importers of Erythromycin from India in Philippines?
The leading importers of Indian Erythromycin in Philippines include NELPA LIFESCIENCES INC, PHILGEN PHARMACEUTICALS INC, GREEN CORE PHARMA INC.NO.460,RM, GREEN CORE PHARMA INC, H.H.C. . NELPA LIFESCIENCES INC is the largest buyer with 9 shipments worth $10.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Erythromycin.
- 2.Supplier/Buyer Matching: 15 Indian exporters and 13 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 46 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
46 Verified Shipments
15 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists